Trial intelligence / Profile preview

Tranexamic Acid in Elderly Patients With Femoral Neck Fractures Undergoing Bipolar Hemiarthroplasty

NCT06289478Recruiting

Start
Jul 2024
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tranexamic acid in femoral neck fracture (3 arms). Primary endpoint: Rate of blood transfusion at 2 years. Started Jul 2024; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

femoral neck fracture

Beyond the preview

Go deeper on NCT06289478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06289478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call